- Home
- ILMN vs CAVA Comparison
ILMN vs CAVA Comparison
Compare ILMN & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- CAVA
- Stock Information
- Founded
- ILMN 1998
- CAVA 2006
- Country
- ILMN United States
- CAVA United States
- Employees
- ILMN N/A
- CAVA N/A
- Industry
- ILMN Medical Specialities
- CAVA Restaurants
- Sector
- ILMN Health Care
- CAVA Consumer Discretionary
- Exchange
- ILMN Nasdaq
- CAVA Nasdaq
- Market Cap
- ILMN 15.9B
- CAVA 15.0B
- IPO Year
- ILMN 2000
- CAVA 2023
- Fundamental
- Price
- ILMN $81.88
- CAVA $90.32
- Analyst Decision
- ILMN Buy
- CAVA Buy
- Analyst Count
- ILMN 18
- CAVA 14
- Target Price
- ILMN $141.94
- CAVA $127.79
- AVG Volume (30 Days)
- ILMN 2.2M
- CAVA 4.3M
- Earning Date
- ILMN 05-01-2025
- CAVA 05-27-2025
- Dividend Yield
- ILMN N/A
- CAVA N/A
- EPS Growth
- ILMN N/A
- CAVA 423.81
- EPS
- ILMN N/A
- CAVA 1.10
- Revenue
- ILMN $4,372,000,000.00
- CAVA $963,713,000.00
- Revenue This Year
- ILMN $0.69
- CAVA $25.56
- Revenue Next Year
- ILMN $4.91
- CAVA $21.07
- P/E Ratio
- ILMN N/A
- CAVA $79.27
- Revenue Growth
- ILMN N/A
- CAVA 32.25
- 52 Week Low
- ILMN $77.54
- CAVA $58.22
- 52 Week High
- ILMN $156.66
- CAVA $172.43
- Technical
- Relative Strength Index (RSI)
- ILMN 35.35
- CAVA 49.01
- Support Level
- ILMN $77.54
- CAVA $81.74
- Resistance Level
- ILMN $89.95
- CAVA $92.04
- Average True Range (ATR)
- ILMN 2.91
- CAVA 4.27
- MACD
- ILMN 0.63
- CAVA 2.25
- Stochastic Oscillator
- ILMN 34.97
- CAVA 81.46
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates the majority of its revenue from the CAVA segment.